Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 23.00M | $ 29.10M | $ 21.70M | $ 36.55M | $ 34.23M |
Total Assets | $ 517.10M | $ 503.30M | $ 421.94M | $ 410.05M | $ 273.16M |
Total Debt | $ 140.00M | $ 124.40M | $ 61.76M | $ 63.81M | $ 13.89M |
Net Debt | $ 117.00M | $ 95.30M | $ 40.06M | $ 27.26M | $ -20.34M |
Total Liabilities | $ 316.20M | $ 294.80M | $ 225.60M | $ 226.13M | $ 122.42M |
Stockholders Equity | $ 193.70M | $ 201.10M | $ 196.34M | $ 183.92M | $ 150.74M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |